Table 1 |
|
|
Demographic, clinical and functional data of the study population (n = 24) |
|
|
Age, year (mean ± SD) |
63.5 ± 7 |
|
Sex (M/F) |
13/11 |
|
Alive/Dead |
16/8 |
|
Smoking history (n %) |
|
|
Ex smokers |
12 (50%) |
|
No smokers |
12 (50%) |
|
Current smokers |
0 (0%) |
|
MRC chronic dyspnea score, n (%) |
|
|
0 |
0 (0%) |
|
1 |
9 (37,5%) |
|
2 |
10 (41,7%) |
|
3 |
3 (12,5%) |
|
4 |
2 (8,3%) |
|
5 |
0 (0%) |
|
PFTs (mean ± SD) |
|
|
FEV1 - FEV1 % pr |
1,97 ± 0,4 - 83,7 ± 15,9% |
|
FVC - FVC % pr |
2,25 ± 0,6 - 76,2 ± 15,2% |
|
FEV1/FVC (ratio) % pr |
88 ± 5,6% |
|
TLC - TLC % pr |
3,31 ± 0,7 - 61,7 ± 11,7 |
|
DLCO - DLCO % pr |
3,23 ± 1,2 - 43,6 ± 14,4% |
|
|
|
|
M/F Male/Female, FEV1 Forced expiratory volume at 1 second, % per cent, FVC Forced vital capacity, TLC Total Lung Capacity, DLCO Diffusion capacity for carbon monoxide, FEV1/FVC: FEV1/FVC ratio |
|
|
Triantafillidou et al. Diagnostic Pathology 2011 6:28 doi:10.1186/1746-1596-6-28 |
|
